{"abstract": "Another major shareholder advisory firm recommended stockholders reject billionaire investor Carl C. Icahn\u2019s slate of nominees to Biogen Idec\u2018s board, reducing his odds of success. ", "web_url": "https://dealbook.nytimes.com/2008/06/12/a-third-proxy-firm-criticizes-icahns-biogen-slate/", "snippet": "", "lead_paragraph": "Another major shareholder advisory firm recommended stockholders reject billionaire investor Carl C. Icahn\u2019s slate of nominees to Biogen Idec\u2018s board, reducing his odds of success. ", "source": "The New York Times", "multimedia": [], "headline": {"main": "A Third Proxy Firm Criticizes Icahn\u2019s Biogen Slate", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2008-06-12T11:32:26+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/ca817d65-8947-5c34-b0b4-6198f760ffad", "word_count": 135, "uri": "nyt://article/ca817d65-8947-5c34-b0b4-6198f760ffad"}